Constantino Fernández-Rivera

7PUBLICATIONS
67CO-AUTHORS
Cardiology (incl. cardiovascular diseases)RehabilitationCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2026
Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

|Mar 07, 2026
Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once-Daily Tacrolimus Formulations: The BITACORA Study.

Amado Andrés, Sara Jiménez, Maria José Aladrén Regidor

|Jan 08, 2025
Efficacy of the Once-Daily Tacrolimus Formulation LCPT Compared to the Immediate-Release Formulation in Preventing Early Post-Transplant Diabetes in High-Risk Kidney Transplant Patients: A Randomized, Controlled, Open-Label Pilot Study (EUDRACT: 2017-000718-52).

Armando Torres, Concepción Rodríguez-Adanero, Constantino Fernández-Rivera

|Dec 23, 2022
Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients.

Constantino Fernández Rivera, Catuxa Rodríguez Magariños, María Calvo Rodríguez

|Sep 23, 2022
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients.

Florentino Villanego, Auxiliadora Mazuecos, Beatriz Cubillo

|Dec 01, 2021
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Constantino Fernandez Rivera, María Calvo Rodríguez, José Luís Poveda

Pageof 2

Frequent Collaborators

2 joint publications

Elena Goicoechea de Jorge

2 joint publications

Edoardo Melilli

2 joint publications

Amado Andrés

1 joint publications

Héctor Martin Merinero